Search

Raj, L., T. Ide, A. U. Gurkar, M. Foley, M. Schenone, X. Li, N. J. Tolliday, et al. 2011. “Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS”. Nature 475: 231-4.

Rampal, R., F. Al-Shahrour, O. Abdel-Wahab, J. P. Patel, J. P. Brunel, C. H. Mermel, A. J. Bass, et al. 2014. “Integrated Genomic Analysis Illustrates the Central Role of JAK-STAT Pathway Activation in Myeloproliferative Neoplasm Pathogenesis”. Blood 123: e123-33.

Ruan, H., N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish. 2002. “Tumor Necrosis Factor-Alpha Suppresses Adipocyte-Specific Genes and Activates Expression of Preadipocyte Genes in 3T3-L1 Adipocytes: Nuclear Factor-KappaB Activation by TNF-Alpha Is Obligatory”. Diabetes 51: 1319-36.

Santagata, S., M. L. Mendillo, Y. C. Tang, A. Subramanian, C. C. Perley, S. P. Roche, B. Wong, et al. 2013. “Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State”. Science 341: 1238303.

Shepard, J. L., J. F. Amatruda, H. M. Stern, A. Subramanian, D. Finkelstein, J. Ziai, K. R. Finley, et al. 2005. “A Zebrafish Bmyb Mutation Causes Genome Instability and Increased Cancer Susceptibility”. Proc Natl Acad Sci U S A 102: 13194-9.

Shipp, M. A., K. N. Ross, P. Tamayo, A. P. Weng, J. L. Kutok, R. C. Aguiar, M. Gaasenbeek, et al. 2002. “Diffuse Large B-Cell Lymphoma Outcome Prediction by Gene-Expression Profiling and Supervised Machine Learning”. Nat Med 8: 68-74.

Shrestha, Y., E. J. Schafer, J. S. Boehm, S. R. Thomas, F. He, J. Du, S. Wang, et al. 2012. “PAK1 Is a Breast Cancer Oncogene That Coordinately Activates MAPK and MET Signaling”. Oncogene 31: 3397-408.

Caicedo, Juan, Sam Cooper, Florian Heigwer, Scott Warchal, Peng Qiu, Csaba Molnar, Aliaksei Vasilevich, et al. 2017. “Data-Analysis Strategies for Image-Based Cell Profiling”. Nature Methods 14 (9): 849-63.

McCamphill, Patrick, Laura Stoppel, Rebecca Senter, Michael Lewis, Arnold Heynen, David Stoppel, Vinay Sridhar, et al. 2020. “Selective Inhibition of Glycogen Synthase Kinase 3α Corrects Pathophysiology in a Mouse Model of Fragile X Syndrome”. Science Translational Medicine 12 (544).

Wagner, Florence, Lina Benajiba, Arthur Campbell, Michel We{\"ıwer, Joshua Sacher, Jennifer Gale, Linda Ross, et al. 2018. “Exploiting an Asp-Glu ‘switch’ in Glycogen Synthase Kinase 3 to Design Paralog-Selective Inhibitors for Use in Acute Myeloid Leukemia”. Science Translational Medicine 10 (431).